Artal Group’s NeueHealth NEUE Stock Holding History

Artal Group’s Portfolio NEUE Stock Details NEUE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-3,819	Closed	-$5.24M	–	158
2021 Q2	$5.24M	Buy	+3,819	New	+$5.23M	0.11%	116

Other funds holding NEUE

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

DIC

Deer IX & Co Larchmont, New York $971M AUM 24.77% 1-Year Est. Return

StepStone Group La Jolla, California $2.16B AUM 20.11% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Tiger Global Management New York $24B AUM 39.59% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Blackstone Inc New York $32.9B AUM 23.66% 1-Year Est. Return

PGH

Partners Group Holding Baar-Zug, Switzerland $1.47B AUM 8.59% 1-Year Est. Return

Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return

Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return

Artal Group's NEUE Position: Q3 2021 in Review

Artal Group sold out of NeueHealth (NEUE) in Q3 2021, closing a stake of 3,819 shares — an estimated $5.24M sold.

Artal Group first reported a position in NEUE in Q2 2021 and held it in 1 quarter. The position peaked at $5.24M in Q2 2021. 102 funds tracked by Wall St. Rank hold NEUE as of Q3 2021.

Artal Group reported no remaining NeueHealth position as of Q3 2021 after selling out during the quarter.
Artal Group sold 3,819 NeueHealth shares in Q3 2021, an estimated $5.24M.
Artal Group first reported a position in NeueHealth in Q2 2021 and held it in 1 quarter.
Artal Group's NeueHealth position peaked at $5.24M in Q2 2021.
102 funds tracked by Wall St. Rank held NeueHealth as of Q3 2021.

Based on Artal Group's 13F filing for Q3 2021, filed 12 Nov 2021.